Back to drug

The Drug-Induced Cardiotoxicity Website and App

Frequency - Incidence

Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XXIV.a

Pneumonitis (interstitial lung disease/ILD)

Publications

Yoshioka F, Kato T, Shima Y, Hatano K, Kawashima A, Fukuhara S, Imamura R, Nonomura N

Drug-induced interstitial pneumonia after intravesical Bacillus Calmette-Guerin administration for bladder cancer with scleroderma.

IJU case reports. 2023;6(2):133-136

Spisarova M, Losse S, Jakubec P, Hartmann I, Kral M, Ehrmann J, Szkorupa M, Studentova H, Melichar B

Bacillus Calmette-Guérin pneumonitis after intravesical instillation: Report of two cases and a review of the literature.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 2024;168(2):181-186

Pommier JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, Laouénan C, Rioux C, Pierre-Audigier C, Meybeck A, Choudat L, Benchikh A, Nguyen S, Bouvet E, Yeni P, Yazdanpanah Y, Joly V

Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.

Infectious diseases (London, England). 2015;47(10):725-31

Tobiume M, Shinohara T, Kuno T, Mukai S, Naruse K, Hatakeyama N, Ogushi F

BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6.

BMC pulmonary medicine. 2014;14:35

Caramori G, Artioli D, Ferrara G, Cazzuffi R, Pasquini C, Libanore M, Guardigni V, Guzzinati I, Contoli M, Rossi R, Rinaldi R, Contini C, Papi A

Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 2013;79(1):44-8

Um SJ, Lee SK, Yang DK

Hypersensitivity pneumonitis following intravesical bacille Calmette-Guérin immunotherapy for superficial bladder cancer.

Journal of investigational allergology & clinical immunology. 2009;19(3):230-2

Salajka F, Pokorny A, Vomela J, Pacík D, Krpensky A, Hrazdirovà A

Severe complications following intravesical BCG instillation.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 2002;57(5-6):321-4

Iantorno R, Nicolai M, Storto ML, Ciccotosto C, Cipollone G, Mastroprimiano G, Tenaglia RL

Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer.

The Journal of urology. 1998;159(5):1639-40

Israel-Biet D, Venet A, Sandron D, Ziza JM, Chretien J

Pulmonary complications of intravesical Bacille Calmette-Guérin immunotherapy.

The American review of respiratory disease. 1987;135(3):763-5

Orihuela E, Herr HW, Pinsky CM, Whitmore WF Jr

Toxicity of intravesical BCG and its management in patients with superficial bladder tumors.

Cancer. 1987;60(3):326-33

McParland C, Cotton DJ, Gowda KS, Hoeppner VH, Martin WT, Weckworth PF

Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy.

The American review of respiratory disease. 1992;146(5 Pt 1):1330-3